Concepedia

J. Rasenack

JR

Statistics

Publications

49

Citations

6.3K

H-Index

35

Active since

1978

Affiliations

University of Freiburg(Current)

University Medical Center Freiburg

Ain Shams University

Goethe University Frankfurt

Beth Israel Deaconess Medical Center

J. Rasenack is an author at University of Freiburg specializing in viral hepatitis, infectious diseases, and antiviral therapy.

Publications per year

1978–2016

49

Publications

49

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

Stefan Zeuzem, S.V. Feinman, J. Rasenack et al. · New England Journal of Medicine · 2000 · 1.2K citations · Full text

, , +14

Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B

Ching‐Lung Lai, Edward Gane, Yun‐Fan Liaw et al. · New England Journal of Medicine · 2007 · 775 citations · Full text

, , +17

Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin

Thomas Berg, Michael Wagner, Samer Nasser et al. · Gastroenterology · 2006 · 519 citations · Full text

, , +16

Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C

Michael Wagner, M Huber, Thomas Berg et al. · Gastroenterology · 2005 · 455 citations

, , +14

Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response

Sanaa M. Kamal, Amr El Fouly, Refaat Kamel et al. · Gastroenterology · 2006 · 216 citations

, , +16

1–5 of 49